| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | - | - | - | - | 17.373 | 129.665 | 91.777 | 60.116 | 44.674 |
| Total Income - EUR | - | - | - | - | - | 17.380 | 129.613 | 91.866 | 60.128 | 44.663 |
| Total Expenses - EUR | - | - | - | - | - | 805 | 102.361 | 92.514 | 54.480 | 22.796 |
| Gross Profit/Loss - EUR | - | - | - | - | - | 16.575 | 27.252 | -648 | 5.648 | 21.867 |
| Net Profit/Loss - EUR | - | - | - | - | - | 16.053 | 25.956 | -1.429 | 5.077 | 21.429 |
| Employees | - | - | - | - | - | 0 | 1 | 1 | 1 | 1 |
Check the financial reports for the company - Biogen Analytics S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | - | - | - | - | 20 | 43 | 2.240 | 1.487 | 683 |
| Current Assets | - | - | - | - | - | 18.477 | 64.707 | 36.562 | 23.973 | 31.629 |
| Inventories | - | - | - | - | - | 0 | 23.147 | 15.319 | 11.773 | 17.848 |
| Receivables | - | - | - | - | - | 8.269 | 20.917 | 4.155 | 6.807 | 7.796 |
| Cash | - | - | - | - | - | 10.208 | 20.642 | 17.088 | 5.394 | 5.985 |
| Shareholders Funds | - | - | - | - | - | 16.095 | 25.035 | 4.508 | 8.770 | 25.101 |
| Social Capital | - | - | - | - | - | 41 | 40 | 41 | 40 | 40 |
| Debts | - | - | - | - | - | 2.403 | 39.715 | 34.294 | 16.691 | 7.210 |
| Income in Advance | - | - | - | - | - | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "7311 - 7311" | |||||||||
| CAEN Financial Year |
7311
|
|||||||||
Comments - Biogen Analytics S.r.l.